|
Glaxo, SK scrips zoom on merger talks
Glaxo, Burroughs Wellcome, Smithkline Pharma and Smithkline Consumer zoomed on news of merger moves on the Bombay Stock Exchange and National Stock Exchange. The four pharma stocks were among the top ten gainers in BSE's specified section. Although the British parents -- Glaxo Wellcome and Smithkline Beecham -- are still negotiating the merger possibilities, stocks spurted by over 15% on European bourses.

Telco abandons cheap finance
The recent three to four per cent spurt in interest rates has forced Telco to abandon its most daring experiment in cheap finance. The company has closed its five per cent flat finance scheme with effect from from January 31, a month after it was launched.
 |
|

Scrips up on Asian rally
ANZ Bank arranges Rs 125 cr for GSFC
HCV sales plummet by 36%
Brokers for Damani as BSE chief
Controversy brewing over J&J advertisement
Re, call rates fall
Asian markets rebound with a vengeance
Consumer affairs dept wants more teeth
 |